Cargando…
Technology clinical trials: Turning innovation into patient benefit
Health care needs to continuously evolve and innovate to maintain the health of populations. Technology has the potential to enable better patient engagement and ownership, as well as optimise therapeutic interventions and data-science approaches to facilitate improved health care decisions. Yet, to...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114771/ https://www.ncbi.nlm.nih.gov/pubmed/34017607 http://dx.doi.org/10.1177/20552076211012131 |
_version_ | 1783691115854036992 |
---|---|
author | Royle, Jennifer K Hughes, Andrew Stephenson, Laura Landers, Dónal |
author_facet | Royle, Jennifer K Hughes, Andrew Stephenson, Laura Landers, Dónal |
author_sort | Royle, Jennifer K |
collection | PubMed |
description | Health care needs to continuously evolve and innovate to maintain the health of populations. Technology has the potential to enable better patient engagement and ownership, as well as optimise therapeutic interventions and data-science approaches to facilitate improved health care decisions. Yet, to date, technological innovation has not resulted in the rate of change that could have been predicted from other sectors. This article discusses multiple reasons for this and proposes a newly tested and deployed solution: the technology clinical trial. The technology clinical trial methodology has been developed through working directly with patients, clinical and medical devicetrial experts. This approach enables researchers to use the complex environment of health care as an opportunity to transform the pace of innovation and create new care pathways. Instead of testing a single innovation, researchers can ‘step back’ and systematically review all areas of the patient's journey for potential optimization. Then integrate novel data science, technological advances, process updates, behavioural science, and patient engagement to co-create a streamlined multidisciplinary solution. As a result, this research has the potential for larger advances due to the emergent benefits that can arise when the individual elements work together as a whole. These potential benefits are then robustly tested, characterised and measured in the trial environment to ensure that future application of the innovative pathway is supported by the robust empirical data health care requires. |
format | Online Article Text |
id | pubmed-8114771 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-81147712021-05-19 Technology clinical trials: Turning innovation into patient benefit Royle, Jennifer K Hughes, Andrew Stephenson, Laura Landers, Dónal Digit Health Essay Health care needs to continuously evolve and innovate to maintain the health of populations. Technology has the potential to enable better patient engagement and ownership, as well as optimise therapeutic interventions and data-science approaches to facilitate improved health care decisions. Yet, to date, technological innovation has not resulted in the rate of change that could have been predicted from other sectors. This article discusses multiple reasons for this and proposes a newly tested and deployed solution: the technology clinical trial. The technology clinical trial methodology has been developed through working directly with patients, clinical and medical devicetrial experts. This approach enables researchers to use the complex environment of health care as an opportunity to transform the pace of innovation and create new care pathways. Instead of testing a single innovation, researchers can ‘step back’ and systematically review all areas of the patient's journey for potential optimization. Then integrate novel data science, technological advances, process updates, behavioural science, and patient engagement to co-create a streamlined multidisciplinary solution. As a result, this research has the potential for larger advances due to the emergent benefits that can arise when the individual elements work together as a whole. These potential benefits are then robustly tested, characterised and measured in the trial environment to ensure that future application of the innovative pathway is supported by the robust empirical data health care requires. SAGE Publications 2021-04-30 /pmc/articles/PMC8114771/ /pubmed/34017607 http://dx.doi.org/10.1177/20552076211012131 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Creative Commons CC BY: This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Essay Royle, Jennifer K Hughes, Andrew Stephenson, Laura Landers, Dónal Technology clinical trials: Turning innovation into patient benefit |
title | Technology clinical trials: Turning innovation into patient benefit |
title_full | Technology clinical trials: Turning innovation into patient benefit |
title_fullStr | Technology clinical trials: Turning innovation into patient benefit |
title_full_unstemmed | Technology clinical trials: Turning innovation into patient benefit |
title_short | Technology clinical trials: Turning innovation into patient benefit |
title_sort | technology clinical trials: turning innovation into patient benefit |
topic | Essay |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114771/ https://www.ncbi.nlm.nih.gov/pubmed/34017607 http://dx.doi.org/10.1177/20552076211012131 |
work_keys_str_mv | AT roylejenniferk technologyclinicaltrialsturninginnovationintopatientbenefit AT hughesandrew technologyclinicaltrialsturninginnovationintopatientbenefit AT stephensonlaura technologyclinicaltrialsturninginnovationintopatientbenefit AT landersdonal technologyclinicaltrialsturninginnovationintopatientbenefit |